Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Voycare is a healthcare services and digital health company focused on cross-border telemedicine and medical tourism rather than therapeutic drug development. The company has operated a Chinese-language platform aimed primarily at women's health, counseling, fertility-related services, medical second opinions, and provider/patient portal functionality. Historically, Voycare also positioned itself as a facilitator for overseas patients, especially Chinese outbound travelers, seeking access to oncology, in vitro fertilization, cosmetic surgery, and wellness services in North and South America. Public disclosures indicate the business became associated with the OTC-traded shell North America Frac Sand, which acquired HTT & CTT/Voycare and later completed a corporate name change to Voycare. Based on the available evidence, Voycare appears to be a commercial-stage healthcare services platform rather than a biotech or pharma pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Voycare.